Best Pharma Stocks in India

Posted by : Ketan Sonalkar | Tue May 28 2024

Best Pharma Stocks in India

Pharma Stocks in India

The Indian pharmaceutical industry is a global powerhouse, ranking third in terms of volume and tenth in terms of value. It caters to a significant portion of the world’s demand for affordable and generic medicines. With a growing domestic market and increasing exports, the Indian pharma sector presents exciting opportunities for investors seeking long-term growth.

This blog explores the best pharma stocks in India, the benefits of investing in them, and factors to consider before making investment decisions.

What are Indian Pharma Stocks?

Indian pharma stocks represent companies listed on Indian stock exchanges that operate in the pharmaceutical sector. These companies develop, manufacture, and market a wide range of pharmaceutical products, including:

  • Generic drugs: Affordable versions of brand-name medications that have gone off-patent.
  • Branded drugs: Innovative drugs developed by pharmaceutical companies and protected by patents.
  • Over-the-counter (OTC) drugs: Medications available without a prescription for minor ailments.
  • APIs (Active Pharmaceutical Ingredients): The raw materials used in the production of finished pharmaceutical products.
  • Contract research and manufacturing services (CRAMS): Services provided by Indian companies to global pharmaceutical companies, including drug discovery, development, and manufacturing.

Overview of Best Pharma Stocks in India (Disclaimer: Not financial advice)

The Indian pharmaceutical industry boasts a diverse range of companies with strong fundamentals and promising growth trajectories. Here are some examples of leading pharma stocks in India, categorized by their area of focus:

  1. Generic Drugs:
  • Cipla: A leading global manufacturer of generic drugs with a strong presence in emerging markets.
  • Dr. Reddy’s Laboratories: A multinational pharmaceutical company known for its high-quality generic formulations and active pharmaceutical ingredients (APIs).
  • Sun Pharmaceutical Industries: A prominent player in the generic drug market with a focus on specialty drugs and complex generics.
S.no Stocks Name Market Capitalization(in Cr) P/E Ratio 5 Years Returns (%)
1. Cipla 1,19,368.7 28.96 162.15
2. Dr. Reddy’s Laboratories 98,161.7 17.6 128.49
3. Sun Pharmaceutical Industries 3,51,910 36.75 245.66

2. Branded Drugs:

  • Divis Laboratories: A leading manufacturer of active pharmaceutical ingredients (APIs) and a growing player in the branded generics market.
  • Torrent Pharmaceuticals: A diversified pharmaceutical company with a strong portfolio of branded drugs across various therapeutic segments.
  • Aurobindo Pharma: A global pharmaceutical company with a growing presence in the branded generics market, particularly in the United States.
S.no Stocks Name Market Capitalization(in Cr) P/E Ratio 5 Years Returns (%)
1. Divis Laboratories 1,12,930 70.58 176.39
2. Torrent Pharmaceuticals 89,825 54.24 252.98
3. Aurobindo Pharma 70,057.75 22.08 77.79

3. CRAMS:

  • Syngene International: A contract research organization (CRO) providing a comprehensive range of drug discovery and development services to global pharmaceutical companies.
  • Jubilant Pharmova: A leading contract manufacturing organization (CMO) offering a wide range of services for the development and manufacturing of pharmaceutical products.
  • Aarti Drugs: A diversified pharmaceutical company with a strong presence in the CRAMS segment, focusing on API and formulation development and manufacturing.
S.no Stocks Name Market Capitalization(in Cr) P/E Ratio 5 Years Returns (%)
1. Syngene International 26,895.51 52.74 100.54
2. Jubilant Pharmov 10,993.6 290.37 40.18
3. Aarti Drugs 4,434 25.86 241.16

Please note: This list is for informational purposes only and should not be considered financial advice. It’s crucial to conduct your own research before making any investment decisions.

Benefits of Investing in Best Pharma Stocks in India

There are several compelling reasons to consider investing in the best pharma stocks in India:

pharma stocks in india- Benefits

  • Strong Industry Growth: The Indian pharmaceutical industry is expected to grow at a CAGR (Compound Annual Growth Rate) of 8-11% over the next five years, driven by factors such as rising healthcare spending, an aging population, and increasing government focus on healthcare infrastructure.
  • Government Support: The Indian government is actively implementing policies to promote the growth of the pharmaceutical industry, such as production-linked incentives (PLIs) and simplified regulatory processes.
  • Affordability: Indian pharmaceutical companies are known for their ability to produce high-quality generic drugs at affordable prices, making them well-positioned to cater to the growing demand for medicines in emerging markets.
  • Innovation: Leading Indian pharma companies are increasingly investing in research and development (R&D) to develop new drugs and formulations, fostering long-term growth prospects.
  • Diversification: The Indian pharmaceutical industry offers a variety of investment options across different segments, allowing investors to diversify their portfolios and mitigate risk.

Factors to Consider Before Investing in Top Pharma Stocks

While the Indian pharma sector presents promising opportunities, careful consideration of these factors is essential before investing:

  • Company Financials: Evaluate the company’s financial health, including its profitability, debt levels, cash flow, and return on equity (ROE).
  • Product Portfolio: Analyze the company’s product portfolio, focusing on its mix of generic and branded drugs, therapeutic areas, and geographic reach.
  • Research & Development (R&D) Capabilities: Assess the company’s commitment to R&D and its pipeline of new drugs under development. A strong R&D focus indicates potential for future growth.
  • Regulatory Environment: The Indian pharmaceutical industry is subject to strict regulations. Understand the company’s compliance record and its ability to navigate the regulatory landscape.
  • Competition: The Indian pharmaceutical industry is highly competitive. Evaluate the company’s competitive advantages, such as its brand recognition, cost structure, and distribution network.
  • Valuation: Analyze whether the stock price reflects the company’s true value. Don’t overpay for a stock, even if the company has good prospects.
  • Management Team: Research the experience and track record of the company’s management team. A strong and experienced management team can significantly impact a company’s success.
  • Investor Risk Tolerance: Consider your own risk tolerance. The pharmaceutical industry is subject to various risks, such as clinical trial failures, regulatory changes, and patent disputes.

Who Should Invest in the Best Pharma Stocks?

Investing in the best pharma stocks in India can be suitable for a variety of investors, including:

  • Long-term Investors: Investors with a long-term investment horizon (5+ years) can benefit from the potential for steady growth in the Indian pharmaceutical industry.
  • Income Investors: Some Indian pharmaceutical companies offer attractive dividend yields, providing a regular stream of income for investors.
  • Growth Investors: Investors seeking high-growth potential can find opportunities in companies with strong R&D capabilities and a focus on innovative drugs.
  • Risk-Tolerant Investors: The Indian pharmaceutical industry is subject to certain risks. Investors comfortable with moderate risk can benefit from the potential rewards of this sector.

It’s important to remember that every investor has unique circumstances and risk tolerance. Consulting with a financial advisor can help you determine if investing in Indian pharma stocks is suitable for your individual financial goals.

Conclusion

The Indian pharmaceutical industry is a vibrant and growing sector with immense potential. By carefully researching individual companies, and considering your investment goals and risk tolerance, you can identify the best pharma stocks in India for your portfolio. Remember, long-term investment, diversification, and a focus on strong fundamentals can be key ingredients for success in the Indian pharmaceutical market.

Disclaimer: This blog is for informational purposes only and should not be considered financial advice. It’s vital to conduct your own research and consult with a qualified financial advisor before making any investment decisions.

icon

100% Safe & Secure Platform.

Univest encrypts all data and transactions to ensure a completely secure experience for our members.

Copyright

2025 Univest. All rights reserved. | Designed with ❤️ in India
About Univest
About: Univest is a cutting-edge stock market platform designed to help traders and investors maximize their returns with expert-driven advisory services and seamless trading execution. Whether you're a seasoned trader or just starting, Univest simplifies your investment journey with actionable trade recommendations, AI-powered portfolio insights, and a fully integrated brokerage experience. With Univest, you gain access to proven stock market advisory, offering expert trade ideas for stocks, futures, options, and commodities. Our one-click trade execution feature eliminates slippage, ensuring instant execution through our advisory-first brokerage. Smart portfolio management allows you to identify underperforming stocks, optimize your investments, and receive real-time alerts. Additionally, Univest provides seamless investment opportunities beyond stocks, including mutual funds, bonds, fixed deposits, and insurance (coming soon). Join over 40 lakh active investors who trust Univest to make informed and profitable trading decisions. Start investing smarter today! 🚀  
Attention Investors : To ensure a smooth trading experience and prevent unauthorized transactions, investors must update their mobile number and email ID with their stockbroker or depository participant. As per regulatory requirements, investors are required to pay a stipulated amount as an upfront margin for trading in the Cash/FO segment. We encourage all investors to regularly check their securities in the Consolidated Account Statement (CAS) issued by depository to verify their holdings.Always verify alerts and transaction details received directly from the exchange or NSDL before proceeding with any trades. Please do not make payments through unverified email links, WhatsApp, or SMS. Always trade through a registered stockbroker and verify all details before making financial decisions.
 
Disclaimer: Investments in the securities market are subject to market risks. Please read all related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit. For more disclaimer /disclosure, visit https://univest.in/stock-broker or Univest App.We collect and use your contact information for legitimate business purposes, including providing updates on our products and services. We do not sell or rent your contact information to third parties. By submitting your details, you authorize us to contact you via Call/SMS, even if you are registered under DND. This authorization remains valid for 12 months.For grievances, please contact us at hello@unibrokers.in .
 
Univest Stock Broking Disclosures
Univest Stock Broking Private Limited - SEBI Reg. No. INZ000317437 (Stock Broker), NSE TM Code: 90392, BSE TM Code: 6866, MCX TM Code: 57290 and ICCL- Self Clearing Member Code: 6866, SEBI Reg. No. IN-DP-779-2024 (Participant), NSDL DP ID: IN304748.
 Risk Disclosures on Derivatives
1. 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
2. On an average, loss makers registered net trading loss close to ₹ 50,000
3. Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
4. Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Attention Investors: As per NSE circular dated July 6, 2022: https://nsearchives.nseindia.com/content/circulars/INSP52900.pdf, BSE circular dated July 6, 2022: https://www.bseindia.com/markets/MarketInfo/DispNewNoticesCirculars.aspx?page=20220706-55, MCX circular dated July 11, 2022: https://www.mcxindia.com/docs/default-source/circulars/english/2022/july/circular-418-2022.pdf?sfvrsn=9401991_0, investors are cautioned to abstain them from dealing in any schemes of unauthorised collective investments/portfolio management, indicative/ guaranteed/fixed returns / payments etc. 
Investors are further cautioned to avoid practices like:
a. Sharing 
i) trading credentials – login id and passwords including OTPs.
ii) trading strategies,
iii) position details.
b. Trading in leveraged products /derivatives like Options without proper understanding, which could lead to losses.
c. Writing/ selling options or trading in option strategies based on tips, without basic knowledge and understanding of the product and its risks.
d. Dealing in unsolicited tips through platforms like Whatsapp, Telegram, Instagram, YouTube, Facebook, SMS, calls, etc.
e. Trading / Trading in “Options” based on recommendations from unauthorised / unregistered investment advisors and influencers.
 Kindly read the Advisory Guidelines For Investors as prescribed by the Exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client’s assets: https://nsearchives.nseindia.com/content/circulars/INSP49434.pdf
Kindly, read the advisory as prescribed by the Exchange with reference to their circular: NSE/ISC/51035 dated January 14, 2022 regarding Updation of mandatory KYC fields by March 31, 2022: https://www.nseindia.com/resources/exchange-communication-circulars# 
Attention Investors: Prevent unauthorised transactions in your Demat account by updating your mobile number with your depository participant. Receive alerts on your registered mobile number for debit and other important transactions in your Demat account directly from NSDL on the same day. Prevent unauthorised transactions in your Trading account by updating your mobile numbers/email addresses with your stock brokers. Receive information on your transactions directly from the Exchange on your mobile/email at the end of the day. Issued in the interest of investors. KYC is a one-time exercise while dealing in securities markets - once KYC is done through a SEBI-registered intermediary (Broker, DP), you need not undergo the same process again when you approach another intermediary. As a business, we don’t give stock tips and have not authorised anyone to trade on behalf of others. If you find anyone claiming to be part of Univest Stock Broking Private Limited and offering such services, please send us an email at hello@unibrokers.in
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.
Update your email ID and mobile number with your stockbroker/depository participant and receive an OTP directly from the depository on your registered email ID and/or mobile number. Check your securities/mutual funds/bonds in the Consolidated Account Statement (CAS) issued by NSDL every month.
Attention Investors: SEBI has established an Online Dispute Resolution Portal (ODR Portal) for resolving disputes in the Indian Securities Market. This circular streamlines the existing dispute resolution mechanism, offering online conciliation and arbitration, benefiting investors and listed companies https://www.sebi.gov.in/legal/circulars/jul-2023/online-resolution-of-disputes-in-the- indian-securities-market_74794.html. ODR portal for Investors - https://smartodr.in/login.
Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances.
arrow down